Global Tissue Diagnostics Market to Reach $5.14 Billion - Analysis & Forecasts to 2022 by Product, Technology, Disease and End User

DUBLIN, March 21, 2018 /PRNewswire/ --

The "Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 6.9%.

The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of this market.

The global tissue diagnostics market is segmented by product, technology, disease, end user, and regions. By product, the market is segmented into instruments and consumables. The consumables segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the widespread use of consumables and advances in technology to develop novel consumables.

By technology, the market is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to account for the largest share of the global tissue diagnostics market during the next five years. Growth in the IVD (in vitro diagnostics) market and the large number of products based on this technology are driving the growth of this market.

On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. The hospitals segment is estimated to account for the largest share of the global market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.

The global tissue diagnostics market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

The factors such as the high degree of consolidation, the high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the tissue diagnostics market. Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), and Sakura Finetek Japan (Japan) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

Market Dynamics

Drivers

• Rising Incidence of Cancer
• Growing Healthcare Expenditure
• Improving Infrastructure for Cancer Diagnosis
• Technological Advancements in Tissue Diagnostics

Restraint

• High Degree of Consolidation

Opportunities

• Emerging Markets
• Growing Demand for Personalized Medicine
• Rising Number of Clinical Trials for Cancer Drugs

Challenges

• Stringent Regulatory Requirements
• Lack of Infrastructure and Low Awareness in Middle- and Low- Income Countries

Trend

• Increasing Number of Reagent Rental Agreements

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown And Data Triangulation
2.4 Research Assumptions

3 Executive Summary

4 Premium Insights
4.1 Tissue Diagnostics: Market Overview
4.2 Geographic Analysis: Tissue Diagnostics Market in Asia, By Country and Technology
4.3 Global Tissue Diagnostics Market, By End User
4.4 Geographical Snapshot of the Global Tissue Diagnostics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraint
5.2.3 Opportunities
5.2.4 Challenges
5.2.5 Trend

6 Tissue Diagnostics Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Antibodies
6.2.2 Kits
6.2.3 Reagents
6.2.4 Probes
6.3 Instruments
6.3.1 Slide-Staining Systems
6.3.2 Scanners
6.3.3 Tissue-Processing Systems
6.3.4 Other Instruments

7 Tissue Diagnostics Market, By Technology
7.1 Introduction
7.2 Immunohistochemistry (IHC)
7.3 In-Situ Hybridization (ISH)
7.4 Digital Pathology And Workflow Management
7.5 Special Staining

8 Tissue Diagnostics Market, By Disease
8.1 Introduction
8.2 Breast Cancer
8.3 Gastric Cancer
8.4 Lymphoma
8.5 Prostate Cancer
8.6 Non-Small Cell Lung Cancer (NSCLC)
8.7 Other Diseases

9 Tissue Diagnostics Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Research Laboratories
9.4 Pharmaceutical Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Tissue Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 Uk
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis

12 Company Profiles
12.1 Roche
12.2 Danaher
12.3 Thermo Fisher Scientific
12.4 Abbott
12.5 Agilent Technologies
12.6 Merck
12.7 Sakura Finetek Japan
12.8 Abcam
12.9 BD
12.10 Qiagen
12.11 Bio Sb
12.12 Biogenex
12.13 Cell Signaling Technology

For more information about this report visit https://www.researchandmarkets.com/research/b6jlgl/global_tissue?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets